We are live on ! Find out more
RNAM

Avidity Biosciences
RNAM

Delisted

RNAM was delisted on the 26th of February, 2026.

Back to rankings

67 hedge funds and large institutions have $755M invested in Avidity Biosciences in 2020 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 16

29% more funds holding

Funds holding: 52 → 67 (+15)

8% more capital invested

Capital invested by funds: $702M → $755M (+$53.6M)

4.13% more ownership

Funds ownership: 67.87% → 72% (+4.1%)

20% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 15

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
67
Holders Change
+15
Holders Change %
+28.85%
% of All Funds
1.35%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
31
Increased
12
Reduced
15
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
+$26.1M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$21.1M
3
BlackRock
BlackRock
New York
+$20.1M
4
PHS
PFM Health Sciences
California
+$12.7M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$7.33M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$11.6M
2
Citadel Advisors
Citadel Advisors
Florida
-$7.72M
3
Franklin Resources
Franklin Resources
California
-$7.11M
4
APM
Avidity Partners Management
Texas
-$6.64M
5
Millennium Management
Millennium Management
New York
-$6.39M
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
26
Artal Group
Luxembourg
$4.01M -$939K -32,500 -19%
Alyeska Investment Group
27
Alyeska Investment Group
Illinois
$3.2M -$3.85M -133,300 -54%
Deutsche Bank
28
Deutsche Bank
Germany
$3.07M +$258K +8,936 +9%
Charles Schwab
29
Charles Schwab
California
$3.04M +$3.12M +107,868 New
Goldman Sachs
30
Goldman Sachs
New York
$2.85M -$1.5M -51,823 -34%
ACH
31
ArrowMark Colorado Holdings
Colorado
$2.22M -$3.5M -121,158 -61%
N
32
Nuveen
North Carolina
$1.83M +$1.88M +64,941 New
O
33
OrbiMed
New York
$1.8M -$3.93M -136,140 -68%
Wells Fargo
34
Wells Fargo
California
$1.5M +$1.54M +53,367 New
Bank of New York Mellon
35
Bank of New York Mellon
New York
$1.31M +$1.35M +46,635 New
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$927K +$951K +32,920 New
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$713K +$732K +25,311 New
TD Asset Management
38
TD Asset Management
Ontario, Canada
$608K +$37.6K +1,300 +6%
CS
39
Candriam SCA
Luxembourg
$563K – – –
Susquehanna International Group
40
Susquehanna International Group
Pennsylvania
$507K +$520K +17,995 New
SFI
41
Susquehanna Fundamental Investments
Pennsylvania
$497K +$510K +17,642 New
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$493K +$506K +17,516 New
HS
43
HighVista Strategies
Massachusetts
$484K +$497K +17,202 New
FAM
44
Fred Alger Management
New York
$457K -$109K -3,757 -19%
CCM
45
CAAS Capital Management
New York
$422K – – –
PIM
46
Platinum Investment Management
Australia
$422K – – –
PPA
47
Parametric Portfolio Associates
Washington
$323K -$325K -11,239 -49%
AC
48
Athanor Capital
New York
$314K +$95.8K +3,314 +42%
DCM
49
Dupont Capital Management
Delaware
$303K +$311K +10,778 New
AIG
50
American International Group
New York
$282K +$289K +10,001 New
1
2
3 4

RNAM Hedge Fund Activity: Q3 2020 in Review

67 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Avidity Biosciences (RNAM) for Q3 2020, worth a combined $755M — up 7.6% from $702M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new RNAM positions and 16 closed out — a net gain of 15 holders — while 12 added to existing stakes and 15 trimmed.

The largest buyer was Federated Hermes, adding an estimated $26.1M. The largest seller was Deerfield Management, cutting an estimated $11.6M.

  • 67 institutional investors held Avidity Biosciences (RNAM) as of Q3 2020, up from 52 in Q2 2020.
  • Funds reported $755M of Avidity Biosciences stock for Q3 2020, up 7.6% quarter-over-quarter.
  • 31 funds opened new Avidity Biosciences positions in Q3 2020 and 16 closed out, a net change of +15 holders.
  • The largest Avidity Biosciences buyer in Q3 2020 was Federated Hermes, an estimated $26.1M added.
  • The largest Avidity Biosciences seller in Q3 2020 was Deerfield Management, an estimated $11.6M sold.

Based on aggregated 13F filings for Q3 2020.